// App-Quantinova.ai

3390 : Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?

Researchers

Presenter

  • Kris P Croome

Principal Investigators

  • Michael J. Kovacs

  • Roberto Hernandez-Alejandro

  • Alejandro Lazo-Langner

Medical Centers

  • University of Western Ontario, London Health Sciences Centre, London,Canada

  • Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada

  • Department of Epidemiology and Biostatistics, University of Western Ontario, London Health Sciences Centre, London, ON, Canada

  • Department of Medicine, University of Western Ontario, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Extrahepatic portal vein obstruction

  • Gastrointestinal bleeding

  • Portal Hypertension

  • Hypertension

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim